Clinical Trial 6313

Stanford, CA 94305


Summary:

The primary objective of this study is to investigate the relationships among findings in structural and functional neuroimaging, cognitive testing and HPA (hypothalamic- pituitary-adrenal) axis dysregulation in psychotic depression.

Are you or someone you know living with severe depression?

  • Symptoms include:
    • sadness
    • loss of interest in activities
    • fatigue or insomnia
    • difficulty concentrating
    • difficulty at work and in social relationships
  • Sometimes severe depression includes unusual experiences such as
    • believing that your illness is a punishment
    • feeling overwhelmed with guilt
    • hearing voices that put you down
    • believing others are trying to harm you
  • This type of depression is called Psychotic Depression and is being studied at the Stanford Depression Research Clinic.
  • This study involves memory assessments, clinical assessments, a MRI scan, and blood sampling.


  • Qualified Participants May Receive:

    Participants continue taking their own medications while in the study and will receive $350 compensation for the completion of the study.


    Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.